Vanderbilt Kennedy Center

January 9, 2024

VUMC receives $13 million grant to coordinate multisite clinical trial for Rett syndrome treatment

Vanderbilt University Medical Center received a $13 million Department of Defense grant to lead a multisite clinical trial that will evaluate repurposed FDA-approved drugs as treatment options for patients with Rett syndrome.

By Danny Bonvissuto
November 3, 2023

Vanderbilt Kennedy Center receives DOD grant to study telehealth deployment across rural areas of Tennessee

By Danny Bonvissuto
September 29, 2023

Vanderbilt Kennedy Center to begin estimating prevalence of cerebral palsy in Middle Tennessee

Vanderbilt Kennedy Center’s Treatment and Research Institute for Autism Spectrum Disorders has received funding to monitor and estimate prevalence of cerebral palsy (CP) in Middle Tennessee.

By VUMC News and Communications
August 7, 2023

Study shows autism profiles can be identified early via tele-assessment with a tool created at VUMC

A study new study by Vanderbilt researchers offers compelling data that many autism profiles can be identified early via tele-assessment.

By Danny Bonvissuto
SENSE Theatre students act in the play Circus del Sé.
July 13, 2023

SENSE Theatre study finds play participation increases social skills in autistic youth

Together with the Vanderbilt Kennedy Center and ACM Lifting Lives, SENSE Theatre recently presented a two-night performance of the play Circus del Sé, written by Blythe Corbett, PhD, James G. Blakemore Professor of Psychiatry and Behavioral Sciences.

By Danny Bonvissuto
July 5, 2023

Julie Lounds Taylor and Pablo Juárez appointed new co-directors of the Vanderbilt Kennedy Center University Center for Excellence in Developmental Disabilities

The Vanderbilt Kennedy Center (VKC) has announced new leadership for its University Center for Excellence in Developmental Disabilities (UCEDD). Julie Lounds Taylor, PhD, and Pablo Juárez, MEd, BCBA, LBA, have succeeded Elise McMillan, JD, who retired June 30.

By VUMC News and Communications
June 21, 2023

Elise McMillan to retire as Vanderbilt Kennedy Center UCEDD director

Elise McMillan, JD, has announced she will retire from the Vanderbilt Kennedy Center this month.
By VUMC News and Communications
January 26, 2023

Hine to lead DDM, TRIAD outreach and training efforts

Jeffrey Hine, PhD, has been named director of Primary Care Outreach and Training for the Vanderbilt Kennedy Center (VKC), the VKC Treatment and Research Institute for Autism Spectrum Disorders and the Division of Developmental Medicine.
By VUMC News and Communications
January 17, 2023

Vanderbilt Kennedy Center seeks adults 18-30 to study effects of noise on brain activity

The Vanderbilt Kennedy Center is seeking adult participants (ages 18 to 30) for a research study investigating the effects of different noise conditions on brain activity during the Attentional Network Task.
By VUMC News and Communications
November 10, 2022

Kennedy Center seeks participants for disabilities research learning sessions

In January, a series of online learning sessions hosted by Vanderbilt Kennedy Center will bring together stakeholders who wish to see research advance toward understanding and solving the health problems that tend to affect adults with IDD.
By Paul Govern
September 8, 2022

Juárez named director of behavior analysis

Pablo Juárez, MEd, BCBA, LBA, has been named director of behavior analysis within the Vanderbilt Kennedy Center and the Division of Developmental Medicine at Vanderbilt University Medical Center.
By VUMC News and Communications
April 28, 2022

Rajaraman named TRIAD director of behavioral analysis

Adithyan Rajaraman, PhD, BCBA-D, LBA, has been named director of the Vanderbilt Kennedy Center Treatment & Research Institute for Autism Spectrum Disorders.
By VUMC News and Communications
December 6, 2021

Potential Rett syndrome drug shows promising results in phase 3 trial

A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.
By Craig Boerner
1 2 3 … 11